Preprint Article Version 1 Preserved in Portico This version is not peer-reviewed

A High Efficacy DNA Vaccine Against Tilapia Lake Virus in Nile Tilapia (Oreochromis niloticus)

Version 1 : Received: 27 July 2021 / Approved: 28 July 2021 / Online: 28 July 2021 (11:11:37 CEST)

A peer-reviewed article of this Preprint also exists.

Yu, N.; Zeng, W.; Xiong, Z.; Liu, Z. A High Efficacy DNA Vaccine against Tilapia Lake Virus in Nile Tilapia (Oreochromis Niloticus). Aquaculture Reports, 2022, 24, 101166. https://doi.org/10.1016/j.aqrep.2022.101166. Yu, N.; Zeng, W.; Xiong, Z.; Liu, Z. A High Efficacy DNA Vaccine against Tilapia Lake Virus in Nile Tilapia (Oreochromis Niloticus). Aquaculture Reports, 2022, 24, 101166. https://doi.org/10.1016/j.aqrep.2022.101166.

Abstract

Tilapia lake virus (TiLV) is the main tilapia-infecting virus worldwide, causing serious economic losses. However, there is no vaccine for this viral disease. Here, TiLV ORF10 (TiLV-ORF10) encoding a protein with abundant epitopes was constructed into the eukaryotic expression vector pcDNA3.1, and used to evaluate the immune protective effects in Nile tilapia (Oreochromis niloticus). RT-PCR and western blot analyses confirmed vaccine plasmid expression in tilapia muscle tissues. Moreover, the transcription levels of immunoglobulin M, toll-like receptor 2, myeloid differentiation factor 88, interleukin 8, tumor necrosis factor alpha, gamma-IFN, and nuclear factor κB immune-related genes were statistically significantly upregulated in the spleen, liver, and kidney of vaccinated tilapias (P < 0.05). TiLV challenge experiments showed that relative percent survival (RPS) was significantly enhanced in fish by this DNA vaccine. Moreover, RPS was enhanced further when using a higher amount of the DNA vaccine (85.72% RPS at a DNA dose of 45 μg pcDNA3.1–ORF10). Vaccination with pcDNA3.1–ORF10 significantly reduced virus replication, as evidenced by the low amount of virus in the spleen, liver, and kidney of vaccinated tilapias after TiLV challenge. Thus, pcDNA3.1–ORF10 could induce protective immunity in tilapia and may be a potential vaccine candidate for controlling diseases caused by TiLV.

Keywords

tilapia; negative-sense RNA virus; Tilapia lake virus; DNA vaccine

Subject

Biology and Life Sciences, Biochemistry and Molecular Biology

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.